A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise

This study is testing a new drug called BGM0504 (a GLP-1 receptor agonist, similar to medications like Ozempic) in people with type 2 diabetes whose blood sugar is not well-controlled through diet and exercise alone (without any diabetes medications). The goal is to assess how safely and effectively it lowers blood sugar. **You may be eligible if...** - You have type 2 diabetes managed only with diet and exercise - Your HbA1c is between 7.5% and 11.0% - Your BMI is 23 or above - Your weight has been stable for at least 3 months **You may NOT be eligible if...** - You have type 1 diabetes - You have had cancer in the past 5 years (some exceptions apply) - You have had pancreatitis (pancreas inflammation) - You are allergic to GLP-1 receptor agonist medications - You are pregnant or breastfeeding - You have a history of alcohol or substance abuse Talk to your doctor to see if this trial is right for you.